Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Joint Bone Spine
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mercredi 23 octobre 2019
Doi : 10.1016/j.jbspin.2019.09.017
accepted : 18 September 2019
Predictive factors of tumour necrosis inhibitor treatment persistence for rheumatoid arthritis: An observational study in 8052 patients
 

Bruno Fautrel a, b, Manon Belhassen c, d, , Christophe Hudry e, Marie-Christine Woronoff-Lemsi f, g, Laurie Levy-Bachelot h, Eric Van Ganse c, d, Florence Tubach i, j
a Sorbonne Universités, UPMC Université Paris 06, GRC 08, 75646 Paris, France 
b Rheumatology Department, AP–HP, Pitié-Salpétrière University Hospital, 83, boulevard de l'Hôpital, 75013 Paris, France 
c PELyon, Pharmacoepidemiologie Lyon, 11, rue Guilaume-Paradin, 69008 Lyon, France 
d HESPER 7425, Health Services and Performance Research, University Claude-Bernard Lyon 1, 8, Avenue Rockefeller, 69003 Lyon, France 
e Hôpital Cochin, AP–HP, 27, Rue du Faubourg Saint-Jacques, 75014 Paris, France 
f CHU Besançon, Boulevard Alexandre-Fleming, 25000 Besançon, France 
g Université Franche-Comté, COMUE UBFC, UMR Inserm 1098, 8, rue du Docteur-Jean-François-Xavier-Girod, 25020 Besançon, France 
h Merck Sharp & Dohme, 10-12 Cours Michelet, 92800 Puteaux, France 
i Sorbonne Université, Inserm, Institut Pierre Louis d’Epidémiologie et de Santé Publique, 75013, Paris, France 
j IPLESP, AP–HP, Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Département Biostatistique Santé Publique et Information Médicale, Centre de Pharmacoépidémiologie (Cephepi), CIC-1421, 75013, Paris, France 

Corresponding author at: Pharmacoepidemiology, Faculté d’Odontologie, UCBL, 11, rue Guillaume-Paradin, 69372 Lyon cedex 08, France.Pharmacoepidemiology, Faculté d’Odontologie, UCBL11, rue Guillaume-ParadinLyon cedex 0869372France

Keywords : Rheumatoid arthritis, Predictive factors, Persistence, Subcutaneous TNF inhibitors




© 2019  Société française de rhumatologie@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline